| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-07 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |